Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Preliminary results of phase I study of CRX-675 for ragweed allergy

July 7, 2005

LAS-34273 demonstrates fast and sustained 24-hour bronchodilator effect

July 6, 2005

Altana and Pfizer terminate Daxas collaboration

July 5, 2005

Enrollment under way in phase I study of LAB CGRP for asthma

July 1, 2005

First European filing for new aerosol inhaler version of Pulmicort

July 1, 2005

Preliminary results from phase I trial of recombinant AAV alpha1-antitrypsin vector gene therapy

June 28, 2005

CAT-354 well tolerated in mild asthmatic patients

June 28, 2005

Antigen Express and Stallergenes partner on novel allergy therapy

June 27, 2005

Recent patents describe therapeutic agents for respiratory and inflammatory disorders

June 23, 2005

New phase I study for inhaled long-acting muscarinic antagonist for COPD

June 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...